Precision NanoSystems joins Danaher’s Life Sciences Platform

Precision NanoSystems (PNI) has been acquired by Danaher Corporation’s Life Sciences platform. PNI is a global leader in technologies and solutions for the development of genetic medicines, including mRNA vaccines and therapeutics.

PNI will join Danaher’s Life Sciences platform and will be complementary to other businesses in the platform, including Cytiva and Pall.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>